
Class 4 medicine recallMedicine · 1 Jun 2022
Napp Pharmaceuticals Limited have identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release tablets incorrectly states strength as 15mg.
Class 4 medicine recallMedicine · 31 May 2022
DEMO SA PHARMACEUTICAL INDUSTRY has informed us that the Product Code/GTIN (PC) number found on the above batch is incorrect. The GTIN number that should have been allocated for this batch is 5200040321010.
Medicine recallMedicine · 30 May 2022
Consilient Health UK Ltd is recalling a specific batch due to limited units from the batch being distributed prior to batch release.
Class 4 medicine recallMedicine · 26 May 2022
Orifarm UK have informed us of an error with the Patient Information Leaflet (PIL) packaged within the packs of certain batches. The product name stated in the heading of the PIL has been spelt…
Class 2 medicine recallHigh riskMedicine · 25 May 2022
hameln pharma ltd are recalling batches of product additional to the batch recalled on 15 February 2022 (reference EL(22)A/06).
Class 2 medicine recallHigh riskMedicine · 17 May 2022
Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated Tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets, resulting in the…
Class 4 medicine recallMedicine · 9 May 2022
GlaxoSmithKline UK Ltd have informed the MHRA that an incorrect version of the Summary of Product Characteristics section 4.2 and the Patient Information Leaflet is inside the sealed pack, and contains unapproved text.
Class 2 medicine recallHigh riskMedicine · 5 May 2022
Pfizer Limited are recalling all batches of Accupro 5mg, 10mg, 20mg, 40mg film-coated tablets as a precautionary measure
Class 2 medicine recallHigh riskMedicine · 28 Apr 2022
Fresenius Kabi Limited are recalling a specific batch of product as a precautionary measure due to the identification of particles in the solution for injection, following routine batch analysis and subsequent batches manufactured on…
Class 2 medicine recallHigh riskMedicine · 27 Apr 2022
Crescent Pharma Limited are recalling a specific batch of Paroxetine 40mg Film Coated Tablets as a precautionary measure.
Class 4 medicine recallMedicine · 21 Apr 2022
Pfizer Limited have informed the MHRA that an outdated version of the Patient Information Leaflet (PIL) has been included in the packaging of the specific batches mentioned in this notification.
Class 2 medicine recallHigh riskMedicine · 11 Apr 2022
USV UK Limited are recalling specific batches of products as a precautionary measure due to out of specification results for impurities during routine stability testing.
Class 2 medicine recallHigh riskMedicine · 28 Mar 2022
Pfizer Ltd are recalling batch number DD4842 as a precautionary measure due to the identification of a nitrosamine above the acceptable limit.
Class 4 medicine recallMedicine · 17 Mar 2022
Brancaster Pharma Limited have notified us of an issue relating to the label of the Water for Injections (solvent) packaged in each finished product pack.
Medicine recallMedicine · 16 Mar 2022
Advanced Accelerator Applications is recalling specific batches of this product as a precautionary measure due to an out of specification result that was identified during stability testing.
Class 4 medicine recallMedicine · 15 Mar 2022
Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons.
Class 4 medicine recallMedicine · 14 Mar 2022
CNX Therapeutics Ltd. have notified the MHRA that the batches of Latuda film-coated tablets listed in this notification will be released without EAN barcodes on the cartons.
Class 4 medicine recallMedicine · 10 Mar 2022
Boots have identified an error with the printed patient information leaflet provided with batches of the Decongestant Tablets and Decongestant with Pain Relief Tablets.
Class 2 medicine recallHigh riskMedicine · 7 Mar 2022
Wockhardt UK Ltd are recalling a batch of Diazepam RecTubes 2.5mg Rectal Solution due to an out of specification result for assay during routine stability testing.
Class 3 medicine recallMedicine · 2 Mar 2022
Kyowa Kirin Services Ltd. are recalling a batch of Isotard 60mg XL Tablets as a precautionary measure due to microfibres/crystals of the Active Pharmaceutical Ingredient (API) being present on the surface of the tablets…
Class 4 medicine recallMedicine · 23 Feb 2022
Atnahs Pharma UK Limited have identified additional missing information on the PIL of the certain product batches.
Class 2 medicine recallHigh riskMedicine · 17 Feb 2022
medac GmbH (t/a medac Pharma LLP) are recalling certain product batches as a precautionary measure due to visual detection of glass lamellae particles during an ongoing stability study.
Class 2 medicine recallHigh riskMedicine · 17 Feb 2022
Uni Health Distribution is aware of a potential issue where the leaflet contained within Efudix 5% w/w cream (2 x 20g) pack, batch 80193439/B may be incorrect.
Class 2 medicine recallHigh riskMedicine · 15 Feb 2022
hameln pharma ltd is recalling a batch of a product as a precautionary measure as remaining vials may no longer be in line with the licensed product specification